News & Events
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
FRANKLIN LAKES, N.J., Feb 3, 2003 (BUSINESS WIRE) -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today it would participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference. The BD presentation will be made on Wednesday, February 5, 2003 at 2:10 p.m. (ET).
The live webcast of BD's presentation can be accessed from the BD website, www.bd.com and will be available for replay on the BD website until 5:00 p.m. (ET), February 12, 2003.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.
CONTACT: BD, Franklin Lakes Patricia A. Spinella, 201/847-5453
|